3 Diabetes Biotechs That Could Surge 50% or More in 2018 Post author:Sam Post published:January 21, 2018 Post category:BioPharma Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace You Might Also Like AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal October 29, 2017 Booming Bay Area Biotechs' Huge Headache: Where to House Their Employees October 12, 2017 <b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017
AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal October 29, 2017
<b>oneservice AG</b>, Announces The Appointment Of <b>Stephen L. Elliott</b> As President <b>Oneservice Inc. North America</b> July 31, 2017